Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
FHLC
342
HOLDINGS
3%
ALSO IN THNR
THNR
19
HOLDINGS
53%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.9% | 8.7% | 8.7% |
|
ABBVIE INC | 6.0% | 5.4% | 5.4% |
|
MERCK & CO. INC. | 4.4% | 5.6% | 4.4% |
|
AMGEN INC | 2.9% | 5.1% | 2.9% |
|
PFIZER INC | 2.3% | 5.1% | 2.3% |
FHLC Overweight Relative to THNR
|
JOHNSON & JOHNSON | 8.6% |
|
UNITEDHEALTH GROUP INC | 5.7% |
|
ELI LILLY & CO | 5.2% |
|
THERMO FISHER SCIENTIFIC INC | 2.7% |
|
ABBOTT LABORATORIES | 2.4% |
|
GILEAD SCIENCES INC | 2.4% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
CVS CAREMARK CORP | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
|
DANAHER CORP | 1.8% |
FHLC Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -8.8% |
 |
INNOVENT BIOLOGICS, INC. | -6.0% |
|
SCHOLAR ROCK HOLDING CORP. | -5.7% |
 |
CHINA PHARMACEUTICAL GROUP | -5.7% |
|
REGENERON PHARMACEUTICALS | -5.2% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -5.1% |
|
VIKING THERAPEUTICS, INC. | -4.5% |
|
HIMS & HERS HEALTH, INC. CLASS A | -4.3% |
 |
ASTRAZENECA PLC | -4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.0% |